Recent Posts
- Genmab and UiO: Aiming to use artificial intelligence to develop new therapeutics
- Summary of the year 2023
- Meet Inven2 at the Nordic Life Science Days
- Licensing validates Norwegian platform technology for the development of tailored monoclonal antibodies
- Authera lands collaborative agreement with argenx